Basel, Switzerland

Christa Hartmann

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christa Hartmann. Retrieved from https://idiyas.com/inventor/christa-hartmann-72rs4l4c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christa Hartmann - Innovative Inventor from Basel, CH

Introduction: Christa Hartmann is a pioneering inventor based in Basel, Switzerland, known for her groundbreaking contributions to various fields of technology and science.

Latest Patents: Christa Hartmann holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing her diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in research and development, Christa Hartmann has led numerous successful projects that have resulted in cutting-edge inventions with real-world applications.

Collaborations: Throughout her career, Christa Hartmann has collaborated with leading universities, research institutions, and multinational companies to further advance her inventions and bring them to the market successfully.

Conclusion: Christa Hartmann's passion for innovation and her relentless drive to push the boundaries of what is possible make her a true trailblazer in the world of inventors, leaving a lasting impact on the industries she touches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…